secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2026-06-12T20:01:09+00:00
Accession:  0001401914-26-000032
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience stockholders approve 1.5M share increase in 2022 plan and ratify auditor
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2022 Stock Incentive Plan adding 1,500,000 shares; total reserve becomes 2,883,333 shares.
- Elected directors Gregory W. Matz (3,752,211 votes for) and Sabrina Martucci Johnson (3,848,085 votes for).
- Ratified Haskell & White LLP as independent auditor for FY2026 (7,754,883 votes for).
- Approved potential future issuances under Lincoln Park Capital equity line (3,771,709 votes for).
- Say-on-pay approved (3,625,596 votes for); board set advisory vote frequency at every year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000140191426000032/0001401914-26-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000140191426000032/dare-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001401914-26-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer